Home > Pressrelease > Kidney Stones Management Market size to exceed $3.2bn by 2028
Kidney Stones Management Market size to exceed $3.2bn by 2028
- Published Date: February 14, 2022
Kidney Stones Management Market size is set to exceed USD 3.2 billion by 2028; according to a new research report by Global Market Insights Inc.
Rising prevalence and recurrence rate of nephrolithiasis is expected to escalate the market expansion of kidney stones management. For instance, in 2021, according to the National Center for Biotechnology Information (NCBI) report, nephrolithiasis is the most common condition affecting the urinary system. It affects about 12% of the world population with a yearly incidence of 600,000 in America, thus stimulating the demand for kidney stones management, thereby fostering the market size.
Preference towards minimally invasive surgeries will boost the market statistics
Growing inclination towards minimally or non-invasive surgical procedures will serve to be a high impact rendering factor in the market expansion. Minimally invasive surgeries offer numerous benefits such as low blood transfusions, minimum complexities, reduced hospital stays and lesser time for recovery. Such benefits of minimally invasive surgeries will spur the market outlook. Additionally, least side effects associated with minimally invasive surgeries as compared to open surgery procedures is expected to upsurge the market potential.
Lack of treatment awareness in low-income countries may restrain the kidney stones management market statistics
Lack of treatment awareness is one of the major roadblocks towards preventing morbidity and mortality related to kidney diseases. Chronic kidney diseases represent a huge burden cost on the healthcare systems of underdeveloped and developing countries due to low awareness about the condition among patients. Lack of awareness may be attributed to low screening and urine testing rate in high-risk diabetes and hypertension patients for kidney related diseases, and as a consequence of poor access to healthcare in underserved regions. Similarly, lack of treatment awareness in low-income countries coupled with unavailability of advanced treatment options including kidney transplant might hamper the market expansion.
Struvite stone formation owing to rising incidence of urinary tract infections is expected to favor the segmental demand
By type, the kidney stones management market is bifurcated into calcium oxalate, calcium phosphate, uric acid, struvite and cysteine stones. Struvite segment exceeded USD 189.5 million in 2021 and is expected to witness considerable CAGR during the analysis timeframe. Kidney stones occur due to formation of crystals of minerals such as calcium and phosphate, often due to low intake of fluids. Bacteria present in urinary tract are responsible for struvite mineral formation. Nearly 9 to 10 percent of all kidney stones are made from struvite. These stones are capable of growing quickly, and eventually block kidney, bladder or ureter leading to complications. Also. struvite stones are more common in women than in men. Thus, increasing UTIs leads to the formation of struvite, thereby fostering the market size.
Browse key industry insights spread across 130 pages with 95 market data tables & 13 figures & charts from the report, “Kidney Stones Management Market Forecasts By Type (Calcium Oxalate, Calcium Phosphate, Uric Acid, Struvite, Cysteine), Diagnostics (Abdominal X-ray, Computed Tomography, Ultrasound, Abdominal MRI, Intravenous Pyelography), Treatment (Extracorporeal Shock Wave Lithotripsy {ESWL}, Ureteroscopy, Percutaneous Nephrolithotomy {PCNL}), Industry Analysis Report, Regional Outlook, Price Trends, Application Potential, Competitive Market Share & Forecast, 2022 – 2028” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/kidney-stones-management-market
Ultrasound diagnostic is a first choice of diagnosis among patients
By diagnostics, the kidney stones management market is classified into abdominal X-ray, computed tomography, ultrasound, abdominal MRI and intravenous pyelography. Ultrasound segment held around 24% revenue share in 2021 and is poised to show tremendous growth during the forthcoming years. Ultrasound is another significant imaging modality that is gaining momentum for kidney stone diagnosis. This non-invasive procedure involves use of sound waves without need for radiation exposure and contrast dye. Hence, this technique is popular in pregnant women and patients who are allergic to contrast dye. Thus, patient’s comfort coupled with elimination of harmful radiations will raise patient preference towards ultrasound, thereby augmenting the product demand.
Growing prevalence of chronic disease, availability of advanced technology and reimbursement pattern in the European region will boost the regional industry outlook
Europe kidney stones management market is expected to exceed USD 860 million by 2028. Various industrialized nations in the Europe are facing an increasing trend of hypertension, diabetes and obesity due to unhealthy diet and lifestyle changes. Since these conditions are considered to be risk factors for kidney stone formation, the prevalence of kidney stones disease is likely to grow in the region. Nearly 20 to 50 million people in Europe were affected with symptomatic kidney stones. In addition to this, kidney stones disease management in the region is positively influenced by availability of technology and reimbursement patterns that vary country wise.
Inorganic strategies including mergers and acquisitions will offer significant growth opportunities to market players
Growing emphasis of manufacturers on developing innovative and effective solutions for kidney stones management will provide lucrative growth opportunities. Notable players operating in kidney stones management market include Boston Scientific, Cook Medical, Allengers Medical Systems, C. R. Bard, Dornier MedTech, Elmed Medical Systems, Coloplast, Medispec and DirexGroup. These industry players adopt several strategies such as acquisitions, mergers, collaborations, geographical expansions and new product launches to sustain competition and grab more business share.